Preclinical evaluation of two neutralizing human monoclonal antibodies against HCV: A potential treatment to prevent HCV re-infection in liver transplant patients Ilan, E., Eren, R., Landstein, D., Kovjazin, R., Galili, Z., Waisman, T., Aviel, S., Terkieltaub, D., Gopher, J., Zauberman, A., Keck, Z. Y., Foung, S., Dagan, S. ELSEVIER SCIENCE BV. 2005: A58

View details for Web of Science ID 000227989900069